Growth and Development group, Vall d'Hebron Research Institute (VHIR), Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Front Endocrinol (Lausanne). 2024 Jul 8;15:1367808. doi: 10.3389/fendo.2024.1367808. eCollection 2024.
Defects in any thyroid hormone synthesis steps cause thyroid dyshormonogenesis (THD). THD due to () gene variants is a cause of congenital hypothyroidism (CH) with a wide clinical spectrum, ranging from mild to severe permanent hypothyroidism. We present high-throughput sequencing results of patients with variants.
A CH high-throughput sequencing-panel of the main genes involved in the regulation of thyroid hormonogenesis was performed to identify those variants that may be related to patient THD phenotype.
We identified 21 gene variants in 19 patients (11.8%) which could explain their phenotype. Ten of those (47.6%) were not previously described. CH was biochemically severe in these 19 patients. Eight of them were reevaluated after one month of discontinuing LT4 treatment and all had severe permanent hypothyroidism. We also identified another 16 patients who presented heterozygous variants, of whom, at reevaluation, five had mild permanent and only one had severe permanent hypothyroidisms.
In this study, 10 novel and 11 previously reported variants in the gene have been identified that could explain the phenotype of 19 patients from non-consanguineous families from a large THD cohort. Although not all these TG gene variants can explain all the patients' THD phenotypes, some of them had severe or mild permanent hypothyroidism at reevaluation.
任何甲状腺激素合成步骤的缺陷都会导致甲状腺激素合成障碍(THD)。由于 ()基因变异导致的 THD 是先天性甲状腺功能减退症(CH)的一个原因,其临床表现广泛,从轻到重的永久性甲状腺功能减退症均有涉及。我们报告了患有 变异患者的高通量测序结果。
对参与甲状腺激素生成调节的主要基因的 CH 高通量测序面板进行了检测,以确定可能与患者 THD 表型相关的 变异。
我们在 19 名患者(11.8%)中发现了 21 种 基因变异,这些变异可以解释他们的表型。其中 10 种(47.6%)是以前没有描述过的。这些 19 名患者的 CH 在生化上都很严重。其中 8 名在停止 LT4 治疗一个月后重新评估,均患有严重的永久性甲状腺功能减退症。我们还发现了另外 16 名携带杂合 变异的患者,其中 5 名在重新评估时患有轻度永久性甲状腺功能减退症,只有 1 名患有严重永久性甲状腺功能减退症。
在这项研究中,我们在 19 名来自非近亲家庭的、表现出甲状腺激素合成障碍的大样本队列患者中,发现了 10 种新的和 11 种以前报道过的 基因变异,这些变异可以解释患者的表型。尽管并非所有这些 TG 基因变异都能解释所有患者的 THD 表型,但其中一些患者在重新评估时存在严重或轻度的永久性甲状腺功能减退症。